Form 4 for SGRY Surgery Partners, Inc.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-01-31 · accession 0001638833-25-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-04 | 2025-01-31 | SGRY | Doherty David T | CFO | A - Grant | $0.00 | +26.8K | 122.5K | +28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-31 | A | A | 26,784 | $0.00 | 122,503 | D | — | — | (F1) Shares issued based on performance vesting criteria for the three-year period ended December 31, 2024 under performance stock unit awards granted to the Reporting Person on February 1, 2022. Shares vested immediately upon certification by the Board on January 31, 2025. |